BioMr. Davenport plays a leading role in all aspects of the firm’s investment strategy and execution focusing on both the healthcare and specialty chemicals industries. He currently serves as Chairman of the Board of Halo Pharmaceutical, AEB Group, Noramco, Tasmanian Alkaloids, TriTex and Wavelength Pharmaceuticals and is a Board Member of Archroma. He previously served as a member of the Board of Directors of IBA Mo ....
Education